Artificial Protein Coronas Enable Controlled Interaction with Corneal Epithelial Cells: New Opportunities for Ocular Drug Delivery.

导出 OA

翻译打印收藏纠错

作者： Carlo,Astarita ^[1] ; Sara,Palchetti ^[2] ; Mina,Massaro-Giordano ^[1] ; Marina,Di Domenico ^[3] ; Francesco,Petrillo ^[1] ; Silvia,Boffo ^[4] ; Giulio,Caracciolo ^[5] ; Antonio,Giordano ^[1]

作者单位： Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA. ^[1] Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. ^[2] Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. ^[3] Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy. ^[4] Department of Ophthalmology, A. O. U. Policlinic-Vittorio Emanuele, 95124 Catania, Italy. ^[5] Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy. ^[6]

关键词 ocular drug delivery ocular surface protein corona

DOI 10.3390/pharmaceutics13060867

PMID 34204664

发布时间 2021-07-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交